Leicester ECMC aims to develop novel therapeutic strategies to treat cancer, particularly with haematological malignancies. A cornerstone of the Centre’s research is to discover and develop novel phytochemicals as potential cancer chemopreventive agents and/or as potential adjuncts to chemotherapy. Biomarkers studies conducted aim to inform treatment decisions and monitor the effectiveness therapies.
Clinical Focus Area
- Medical Oncology
- Haematology Oncology
- Pancreas Cancer
- Lung Cancer
- Colorectal Cancer
- Bladder Cancer
Scientific Focus Area
- Biomarkers of disease diagnosis
- Biomarkers of relapse
- Primary stem cell models
- Mechanisms of chemoprevention
Disease Focus Area
For further information on the goals and objectives of Leicester ECMC go to:
Leicester ECMC principal investigators and staff have a range of skills and expertise.
Leicester ECMC has access to a range of research facilities that are utilised in studies.